Thomas Stoker

Affiliations: 
Management Massachusetts Institute of Technology, Cambridge, MA, United States 
Google:
"Thomas Stoker"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Stoker TB, Mason SL, Greenland JC, et al. (2021) Huntington's disease: diagnosis and management. Practical Neurology
Stoker TB, Holden ST, Barker RA. (2021) Correction to: Late‑onset Huntington's disease associated with CAG repeat lengths of 30 and 31. Journal of Neurology
Stoker TB, Holden ST, Barker RA. (2021) Late-onset Huntington's disease associated with CAG repeat lengths of 30 and 31. Journal of Neurology
Stoker TB, Andresen KER, Barker RA. (2020) Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society
Stoker TB, Barker RA. (2020) Recent developments in the treatment of Parkinson's Disease. F1000research. 9
Stoker TB, Camacho M, Winder-Rhodes S, et al. (2020) Impact of variants on long-term clinical progression and mortality in incident Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry
Stoker TB, Camacho M, Winder-Rhodes S, et al. (2020) A common polymorphism in is associated with accelerated motor decline in -Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry
Birtele M, Sharma Y, Kidnapillai S, et al. (2019) Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons. Febs Letters
Stoker TB, Torsney KM, Barker RA. (2018) Emerging Treatment Approaches for Parkinson's Disease. Frontiers in Neuroscience. 12: 693
Stoker TB, Barker RA. (2018) Regenerative Therapies for Parkinson's Disease: An Update. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
See more...